BioSpace News Archive

“I personally deal with the pain associated with sciatica and as a licensed massage therapist I treat clients with this issue,” said an inventor from Macon, Ga. “This inspired me to develop a product to relieve the pain associated with sitting for long periods of time.”

Berkeley Research Group (BRG) announced today that Orlando L. Alvarez Jr. has joined the firm as a managing director in its Healthcare Performance Improvement

HCTec, a leading provider of hospital IT and revenue cycle workforce optimization solutions, announced today the addition of three new senior leaders within the organization

Pathway OME announces their strategic partnership with Standard Process and Rainbow Genomics, respectively

Primary and Secondary Endpoints Achieved with Statistical Significance

Alkermes plc will host a conference call and webcast presentation at 8:30 a.m. ET (1:30 p.m. BST) on Tuesday, Oct. 23, 2018, to discuss the company’s third quarter 2018 financial results. Management will also provide an update on the company.

Eiger BioPharmaceuticals, Inc. today announced Phase 2 ULTRA study results in primary and secondary lymphedema of the lower limb demonstrated no improvement of ubenimex over placebo in the primary endpoint of skin thickness and secondary endpoints of limb volume and bioimpedance. No safety signals attributed to ubenimex were identified.

ICF (NASDAQ:ICFI), a global consulting and digital services provider, was awarded a re-compete contract by the U.S. Agency for International Development (USAID) to continue to implement its Demographic and Health Surveys Program (DHS)

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) will report its third quarter 2018 financial results on Wednesday, October 24, 2018 after the financial markets close

Evolent Health, Inc. today announced that it intends to offer $125.0 million aggregate principal amount of convertible senior notes due 2025, subject to market and other conditions.